SOPHiA GENETICS Reaches New Analytical Heights with its Whole Exome Solution

SOPHiA Whole Exome Solution (WES) now includes accurate CNV detection, making it a powerful application for healthcare professionals in their fight against rare diseases.

Houston, Texas, USA – 18th October 2019: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today at the American Society of Human Genetics Annual Meeting (ASHG) the release of the new version of SOPHiA Whole Exome Solution. This advanced genomic application is reducing the overall turnaround time, thus accelerating rare disease characterization.